Its regulation by androgenic signals is furthermore clinically relevant for hormone-sensitive cancer types and thus determined that the significant overexpression of AGR2 in tumors vs. normal tissues in this study would concur with a plethora of evidence indicating its putative role as a diagnostic and prognostic marker and a potential therapeutic target. Here, AGR2 is linked to cancer.